HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 277, Issue 39, 36766-36769, September 27, 2002

This Article Abstract Full Text (PDF) All Versions of this Article: 277/39/36766    most recent M205270200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Colmenares, M. Articles by Rivas, L. Search for Related Content PubMed PubMed Citation Articles by Colmenares, M. Articles by Rivas, L. Social Bookmarking                      What's this?

Dendritic Cell (DC)-specific Intercellular Adhesion Molecule 3 (ICAM-3)-grabbing Nonintegrin (DC-SIGN, CD209), a C-type Surface Lectin in Human DCs, Is a Receptor for Leishmania Amastigotes^*

María Colmenares, Amaya Puig-Kröger, Oscar Muñiz Pello^§, Angel L. Corbí^¶, and Luis Rivas

From the Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, Velázquez 144, 28006 Madrid, Spain

Received for publication, May 29, 2002, and in revised form, July 10, 2002

	ABSTRACT

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

Dendritic cells (DCs) play a critical role in the initiation of the immunological response against Leishmania parasites. However, the receptors involved in amastigote-dendritic cell interaction are unknown, especially in absence of opsonizing antibodies. We have studied the interaction of Leishmania pifanoi axenic amastigotes with the C-type lectin DC-specific intercellular adhesion molecule (ICAM)-3-grabbing nonintegrin (DC-SIGN, CD209), a receptor for ICAM-2, ICAM-3, human immunodeficiency virus gp120, and Ebola virus. L. pifanoi amastigotes interact with immature human dendritic cells and CD209-transfected K562 cells in a time- and dose-dependent manner. Leishmania amastigote binding to human dendritic cells and DC-SIGN-transfected cells is inhibited by a function-blocking DC-SIGN-specific monoclonal antibody. More importantly, this monoclonal antibody dramatically reduces internalization of Leishmania amastigotes by immature human DCs. These results constitute the first description of a nonviral pathogen ligand for DC-SIGN and provide evidence for a relevant role of DC-SIGN in Leishmania amastigote uptake by dendritic cells. Our finding has important implications for Leishmania host-cell interaction and the immunoregulation of cutaneous leishmaniasis.

	INTRODUCTION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

Leishmaniasis is a vector-borne parasitic disease with a broad range of clinical manifestations, from local cutaneous lesions to life-threatening visceral disease, mainly caused by differences among Leishmania species and the immunological status of the mammalian host. The parasite exists in two developmental stages; the flagellated promastigote is transmitted with the bite of the sand fly (insect vector) to the mammalian host, where it transforms into the amastigote stage. Leishmania amastigote infects mononuclear phagocytes, a key factor of the immune response against the parasite. This intracellular location potentially allows the parasite to subvert the effector and regulatory functions of these cells.

Cutaneous antigen-presenting cells, more specifically, epidermal Langerhans cells and dermal dendritic cells (DCs),¹ are actively involved in the surveillance of their environment (1, 2). Given their proximity to the site of parasite delivery, the role of dendritic cells must be critical in initiating Leishmania-specific immune responses (3). For Leishmania amazonensis (Leishmania mexicana complex), both amastigotes and metacyclic promastigotes infect DCs (4), although the ability of Langerhans cells and DCs to take up other Leishmania species is still a matter of debate (5, 6). Langerhans cells and DCs within cutaneous lesions are parasitized by Leishmania in vivo in both human (7-9) and experimental murine (10, 11) cutaneous leishmaniasis.

To our knowledge, specific receptors for Leishmania on DCs have not yet been characterized. Dendritic cells express a wide variety of pathogen-associated molecular pattern receptors, including numerous C-type lectin and lectin-like receptors (12). Given the fact that Leishmania spp. surface displays an abundance of mannose-rich glycoconjugates (13), a reasonable hypothesis is that lectin-oligosaccharide interactions are involved in parasite recognition.

Dendritic cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN, CD209) is a cell surface C-type lectin expressed on dendritic cells and involved in cell-cell interactions through its capacity to bind ICAM-3 and ICAM-2 (14, 15). DC-SIGN is also capable of binding HIV-1 gp120 (16) and Ebola virus (17). In the present report we have assessed the participation of DC-SIGN on Leishmania pifanoi axenic amastigote binding and uptake by human monocyte-derived dendritic cells (MDDCs). Our results demonstrate that amastigotes bind specifically and with high avidity to DC-SIGN, suggesting a role for this novel receptor in the outcome of the immune responses against Leishmania.

	EXPERIMENTAL PROCEDURES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

Reagents and Antibodies-- The DC-SIGN-specific monoclonal antibody (MR-1) has been described previously (18). It was characterized (IgG1) and quantified by sandwich enzyme-linked immunosorbent assay (SBA Clonotyping System; SouthernBiotech, Birmingham, AL). The monoclonal antibody TS1/18 (IgG1, anti-CD18) was used as isotype-matched control. Soluble mannan from Saccharomyces cerevisiae (M-7504; Sigma) was prepared as a 2 mg/ml stock solution in PBS, sterile-filtered, and used at the indicated concentrations. L. pifanoi amastigote glycosylinositolphospholipids were purified by successive extraction of whole parasite with organic solvents as described previously (19), analyzed by TLC, and stored as a 10 mg/ml sterile-filtered stock solution in PBS (1% Me₂SO). Recombinant human ICAM-3/Fc chimera was purchased from R&D Systems (Abingdon, United Kingdom).

Parasites-- L. pifanoi MHOM/VE/60Ltrod axenic amastigotes were grown at 31 °C in simplified F29 medium containing 20% heat-inactivated fetal bovine serum (20). For binding experiments, parasites were labeled with the fluorescent dye CFSE (Molecular Probes, Leiden, The Netherlands) before cell adhesion, as described previously (4). This process neither alters nor impairs parasite multiplication (21), as determined in control experiments.

Cells-- Immature MDDCs were prepared from peripheral blood monocytes using interleukin 4 (1000 units/ml) and granulocyte macrophage colony-stimulating factor (1000 units/ml) (18, 22). K562 cells were cultured in RPMI 1640 medium supplemented with 10% fetal calf serum, 2 mM glutamine, and 10 µg/ml gentamicin (complete medium). K562 cells transfected with DC-SIGN (K562-CD209 cells) (18) were grown in complete medium supplemented with 300 µg/ml G418.

Parasite Binding Assays-- Immature MDDCs, K562 cells, or K562-CD209 cells were resuspended in complete medium and aliquoted in 24-well plates (2 × 10⁵ cells/well). CFSE-labeled parasites were added onto the cells at the indicated ratio, and cells were incubated at 37 °C for the period of time indicated in each experiment. Afterward, cells were fixed (1% paraformaldehyde in PBS) for 1 h at room temperature, mounted in Mowiol (Calbiochem), and analyzed on a Nikon Eclipse E800 microscope (Nikon, Melville, NY) equipped for epifluorescence. Alternatively, cells with and without attached parasites were resolved by flow cytometry in two peaks of low and high fluorescence intensity, using an EPICS-CS (Coulter Científica, Madrid, Spain). For inhibition assays, cells were washed with PBS-1 mM EDTA and preincubated for 10 min at room temperature with either MR-1 antibody (1.2 µg/ml, unless otherwise indicated), irrelevant antibodies (100 µg/ml human immunoglobulins or 16 µg/ml anti-CD18 TS1/18 isotype control), EGTA (5 mM), soluble mannan (300 µg/ml), or purified L. pifanoi amastigote glycosylinositolphospholipids (5 µg/ml) in complete medium before parasite addition.

DC-SIGN Adhesion Assays-- DC-SIGN-dependent adhesion of MDDCs was evaluated using ICAM-3/Fc. 96-well microtiter EIA II-Linbro plates were coated overnight with ICAM-3/Fc at 3 µg/ml in 100 mM NaHCO₃, pH 8.8, at 4 °C, and the remaining sites were blocked with 0.4% bovine serum albumin for 2 h at 37 °C. MDDCs were labeled in complete medium with the fluorescent dye 2',7'-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein acetoxymethyl ester (Molecular Probes) and then preincubated for 20 min at 37 °C in RPMI 1640 medium containing 0.4% bovine serum albumin and function-blocking antibodies against CD209 (MR-1), CD18 (TS1/18), or mannan at 100 µg/ml. Cells were then allowed to adhere to each well for 15 min at 37 °C. Unbound cells were removed by three washes with warm RPMI 1640 medium, and adherent cells were quantified using a fluorescence analyzer.

Infection of DCs with Leishmania Parasites-- DCs were adjusted to 10⁶ cells/well in 24-well plates and incubated at 37 °C with parasites at different ratios for 1 h. For inhibition assays, cells were washed with PBS-1 mM EDTA and preincubated for 10 min at room temperature with either MR-1, TS1/18, or soluble mannan in complete medium before parasite addition. After removal of unbound parasites by washing, DC-Leishmania samples were incubated at 34 °C for 48 h. Afterward, cells were washed with PBS, fixed with methanol, and stained with Giemsa to visualize amastigote-infected DCs. The percentage of infected DCs and the parasite:DC ratio were determined by light microscopy examination of at least 200 cells.

	RESULTS

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

L. pifanoi Amastigotes Specifically Bind to DC-SIGN-- Preliminary experiments revealed that L. pifanoi axenic amastigotes were efficiently internalized by human MDDCs (see below). In order to explore whether DC-SIGN was involved in amastigote binding, we first analyzed the interaction of axenic amastigotes with K562 cells transfected with DC-SIGN (K562-CD209 cells). L. pifanoi axenic amastigotes bound to transfected cells, but not to untransfected cells, in a dose-dependent manner, as evaluated by flow cytometry using CFSE-labeled parasites (Fig. 1). Maximal binding was observed within the 1:10 to 1:5 range by using distinct K562-CD209:amastigote ratios (1:1, 1:5, and 1:10). Accordingly, and to avoid an excess of parasites, a ratio of 1:5 was used for the rest of kinetic and competition assays. The binding of amastigotes to K562-CD209 was fast and reached saturation at 1 h (Fig. 2). Importantly, the anti-DC-SIGN MR-1 monoclonal antibody completely blocked amastigote binding to K562-CD209 cells (Fig. 2), confirming the involvement of DC-SIGN in this interaction. Soluble mannan (300 µg/ml) only caused a 30% reduction in amastigote binding (Fig. 2), whereas Leishmania glycosylinositolphospholipids, high mannose-containing molecules abundantly present on promastigote and amastigote plasma membranes (23, 24), did not inhibit amastigote binding at 5 µg/ml (roughly equivalent to 2 × 10⁷ amastigotes/ml) (25) (Fig. 2). Therefore, DC-SIGN functions as a receptor for L. pifanoi amastigotes, whose cell attachment can be partially competed by mannan.

View larger version (19K): [in this window] [in a new window]   Fig. 1.   L. pifanoi amastigotes bind to DC-SIGN-expressing K562 cells. K562 or K562-CD209 cells were incubated with CFSE-labeled amastigotes at different ratios for 2 h at 37 °C. The proportion of cells with bound amastigotes was quantified by flow cytometry after gating on K562 cells and determining the percentage of fluorescence-positive cells. Two arbitrary regions were established: K562 with unbound parasites and fluorescent K562 due to CFSE-labeled bound amastigotes. For comparative purposes, scales were normalized relative to the number of cells without bound parasites. The low and high fluorescence profiles represent amastigote-free K562 cells and cells with bound parasites, as indicated.

View larger version (26K): [in this window] [in a new window]   Fig. 2.   L. pifanoi amastigotes bind specifically to DC-SIGN on K562-CD209 cells. K562-CD209 cells were either left untreated (control) or pretreated with MR-1 (1.2 µg/ml), soluble mannan (300 µg/ml), or Leishmania purified glycosylinositolphospholipids (5 µg/ml) and then incubated at 37 °C with CFSE-labeled amastigotes at a 1:5 cell:parasite ratio for the indicated period of time. The proportion of cells with bound amastigotes was quantified by flow cytometry after gating on K562 cells and determining the percentage of high fluorescence cells. Two arbitrary regions were established: K562 with unbound parasites and fluorescent K562 due to CFSE-labeled bound amastigotes. For comparative purposes, scales were normalized relative to the number of cells without bound parasites.

MDDCs Bind L. pifanoi Axenic Amastigotes via DC-SIGN-- The role of DC-SIGN in amastigote uptake by dendritic cells was initially assessed by preincubation of human immature MDDCs with an excess of anti-DC-SIGN antibody or soluble mannan before the addition of CFSE-labeled axenic amastigotes (1:5 ratio, 2 h, 37 °C). Pretreatment of MDDCs with MR-1 antibody reduced parasite binding in a dose-dependent manner at more than 30 ng/ml (Fig. 3). The dose-dependent inhibitory effect of the MR-1 antibody demonstrates the specificity of the DC-SIGN-Leishmania amastigote interaction. As expected, binding was completely inhibited by EGTA, an inhibitor of C-type lectin-mediated interactions, but not by human immunoglobulins or the isotype control anti-CD18 TS1/18 antibody (Fig. 3). On the other hand, pretreatment with mannan weakly affected amastigote binding to MDDCs.

View larger version (24K): [in this window] [in a new window]   Fig. 3.   The anti-DC-SIGN MR-1 antibody reduces amastigote binding to MDDCs. MDDCs, either left untreated (control) or pretreated for 10 min at room temperature with MR-1 (left panels), irrelevant antibodies (human immunoglobulins, anti-CD18), soluble mannan, or EGTA, were incubated with CFSE-labeled amastigotes at a ratio 1:5 for 2 h at 37 °C. The percentage of DCs with bound amastigotes was quantified by flow cytometry after gating on MDDCs. The specific competitor used in each experiment is indicated next to the corresponding panel. Two arbitrary regions were established: MDDCs with unbound parasites (C) and fluorescent MDDCs due to CFSE-labeled bound amastigotes (G). For comparative purposes, scales were normalized relative to the number of cells without bound parasites.

Essentially the same results were obtained after microscopic examination. As shown in Fig. 4A, the number of amastigotes bound per DC was reduced in the presence of 1.2 µg/ml anti-DC-SIGN MR-1 antibody (17.7 ± 4.9 versus 7.25 ± 2.0 amastigotes/DC), whereas no effect was observed with the isotype-matched TS1/18 antibody at 16 µg/ml. These results further confirmed that DC-SIGN contributes to amastigote binding onto the DC surface. In agreement with the flow cytometry data (Fig. 3), mannan had no significant effect on the number of amastigotes bound per DC (Fig. 4A), despite the fact that it effectively abrogated the DC-SIGN-dependent MDDC binding to immobilized ICAM-3 (Fig. 4B).

View larger version (61K): [in this window] [in a new window]   Fig. 4.   L. pifanoi amastigotes bind specifically to DC-SIGN on MDDCs. A, immature human MDDCs were either left untreated (control) or pretreated with a control antibody (TS1/18), MR-1, or soluble mannan and then incubated with CFSE-labeled amastigotes at a ratio of 1:5. After 2 h at 37 °C, representative fields of each sample were photographed on an epifluorescence microscope (×1200). B, enzyme-linked immunosorbent assay plates were coated with ICAM-3 and incubated with 2',7'-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein, acetoxymethyl ester-labeled MDDCs in the presence of antibodies against DC-SIGN (MR-1), CD18 (TS1/18), or mannan (100 µg/ml). Cells were then allowed to adhere to each well for 15 min at 37 °C and quantified using a fluorescence analyzer.

To test whether DC-SIGN-L. pifanoi amastigote interaction had a physiological significance in MDDC infection, immature cells were left untreated (control) or preincubated with MR-1 antibody or mannan (500 µg/ml) and then incubated with axenic amastigotes at a 1:5 DC:parasite ratio. After 48 h, infection was evaluated by examination of at least 200 Giemsa-stained cells. L. pifanoi axenic amastigotes were efficiently internalized by human immature MDDCs in the absence of opsonizing antibodies (82.5% of DCs infected), whereas pretreatment of MDDCs with MR-1 antibody significantly reduced the number of infected cells (82.5% versus 7.4%) (Table I). As observed in binding experiments, incubation with anti-CD18 did not reduce the percentage of infected cells (91.0%). Again, mannan partially inhibited Leishmania internalization into MDDCs. Taken together, these results demonstrate that, in the absence of Fc receptor-mediated interactions, DC-SIGN is a functionally relevant receptor for binding and internalization of L. pifanoi amastigotes on dendritic cells.

	DISCUSSION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

Early events occurring at the site of delivery of Leishmania include infection of host cells by metacyclic promastigotes followed by their intracellular transformation into amastigote. Once released into the extracellular milieu, amastigotes invade new cells and thereby disseminate the infection. In the first rounds of this expansive cycle, specific antibodies are absent, precluding opsonizing mechanisms from contributing to parasite uptake. Infection of murine and human DCs by amastigotes is clearly documented in the literature (7-11), although the receptors involved remain unknown. According to the available literature, opsonization by specific antibodies may play a major role in targeting and entry of the parasite into the host cells (26). Because most of the Leishmania amastigote-dendritic cell studies were carried out with tissue-derived parasites, known to be opsonized by antibodies, the participation of opsonization-independent mechanisms might have been masked. In the present study we have used axenic amastigotes, devoid of opsonizing antibodies, in order to analyze the participation of the receptor DC-SIGN in binding and internalization of Leishmania amastigotes. Our results demonstrate that axenic amastigotes specifically bind to DC-SIGN both on K562-CD209 cells and MDDCs. Because MR-1 antibody dramatically reduced amastigote binding to and internalization into DCs, our results suggest an important role for this receptor in the early infection of DCs by Leishmania.

Unlike MDDC binding to ICAM-3, mannan did not completely block amastigote binding to dendritic cells, in agreement with previous data on the failure of mannan to inhibit Leishmania amastigote-macrophage interactions (27). Several alternative explanations might account for the incomplete inhibitory effect of mannan on the DC-SIGN-Leishmania interaction. First, Leishmania binding sites on DC-SIGN might differ from those involved in mannan binding. In this regard, site-directed mutagenesis has shown that ICAM-3- and HIV gp120-binding sites are not completely identical and that HIV gp120 recognition by DC-SIGN is not dependent on glycosylation (28). Second, the overall affinity of the Leishmania ligand(s) for DC-SIGN might exceed that of mannan. This alternative is supported by the fact that subtle changes in the oligosaccharide structure of related mannose-rich molecules lead to substantial differences in their affinity for DC-SIGN (29). Furthermore, because the parasite could behave as a multivalent ligand, the possibility of cooperative effects on the interaction between Leishmania and DC-SIGN-expressing cells cannot be ruled out.

To our knowledge, this is the first description of DC-SIGN as a receptor for nonviral pathogen. Moreover, because pathogens are known to alter dendritic cell effector functions (30), it is tempting to speculate that DC-SIGN-Leishmania interactions might condition the initiation of the pathological immune response caused by L. mexicana complex parasites. Further studies on the DC-SIGN-Leishmania interaction will undoubtedly increase our understanding of the Leishmania infection process and will pave the way for alternative strategies to fight the disease.

	ACKNOWLEDGEMENTS

We thank Dr. P. Lastres and Dr. M. A. Ollacarizqueta for assistance with flow cytometry and epifluorescent microscopic analyses, respectively.

	FOOTNOTES

^* This work was supported in part by Grants SAF98/0068 (Comisión Interministerial de Ciencia y Tecnología), 08.3/0026/2000.1 (Comunidad de Madrid), and 01/0063-01 (Fondo de Investigaciones Sanitarias) (to A. L. C.) and Programa General de Grupos Estratégicos (Comunidad Autónoma de Madrid), Grant 99/0025-02 (Fondo de Investigaciones Sanitarias), and Grant QLRT-2000-01404 (European Union) (to L. R.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Supported by a postdoctoral fellowship (Comunidad de Madrid).

^§ Supported by a grant from the Fundación Renal Iñigo Alvarez de Toledo.

^¶ To whom correspondence should be addressed. Tel.: 34-915-611-800, ext. 4312; Fax: 34-915-627-518; E-mail: acorbi@cib.csic.es.

Published, JBC Papers in Press, July 16, 2002, DOI 10.1074/jbc.M205270200

	ABBREVIATIONS

The abbreviations used are: DC, dendritic cell; MDDC, monocyte-derived DC; ICAM intercellular adhesion molecule, DC-SIGN, DC-specific ICAM-3-grabbing nonintegrin (CD209); CFSE, 5,6-carboxyfluorescein succinimidyl ester; HIV, human immunodeficiency virus; PBS, phosphate-buffered saline.

	REFERENCES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				R. T. Martinez-Nunez, F. Louafi, P. S. Friedmann, and T. Sanchez-Elsner MicroRNA-155 Modulates the Pathogen Binding Ability of Dendritic Cells (DCs) by Down-regulation of DC-specific Intercellular Adhesion Molecule-3 Grabbing Non-integrin (DC-SIGN) J. Biol. Chem., June 12, 2009; 284(24): 16334 - 16342. [Abstract] [Full Text] [PDF]

				Y. Abe, Y. Kuroda, N. Kuboki, M. Matsushita, N. Yokoyama, and N. Kojima Contribution of Complement Component C3 and Complement Receptor Type 3 to Carbohydrate-dependent Uptake of Oligomannose-coated Liposomes by Peritoneal Macrophages J. Biochem., November 1, 2008; 144(5): 563 - 570. [Abstract] [Full Text] [PDF]

				J. Alvar, P. Aparicio, A. Aseffa, M. Den Boer, C. Canavate, J.-P. Dedet, L. Gradoni, R. Ter Horst, R. Lopez-Velez, and J. Moreno The Relationship between Leishmaniasis and AIDS: the Second 10 Years Clin. Microbiol. Rev., April 1, 2008; 21(2): 334 - 359. [Abstract] [Full Text] [PDF]

				D. Serrano-Gomez, E. Sierra-Filardi, R. T. Martinez-Nunez, E. Caparros, R. Delgado, M. A. Munoz-Fernandez, M. A. Abad, J. Jimenez-Barbero, M. Leal, and A. L. Corbi Structural Requirements for Multimerization of the Pathogen Receptor Dendritic Cell-specific ICAM3-grabbing Non-integrin (CD209) on the Cell Surface J. Biol. Chem., February 15, 2008; 283(7): 3889 - 3903. [Abstract] [Full Text] [PDF]

				S. Meyer, B. Tefsen, A. Imberty, R. Geyer, and I. van Die The C-type lectin L-SIGN differentially recognizes glycan antigens on egg glycosphingolipids and soluble egg glycoproteins from Schistosoma mansoni Glycobiology, October 1, 2007; 17(10): 1104 - 1119. [Abstract] [Full Text] [PDF]

				D. Serrano-Gomez, R. T. Martinez-Nunez, E. Sierra-Filardi, N. Izquierdo, M. Colmenares, J. Pla, L. Rivas, J. Martinez-Picado, J. Jimenez-Barbero, J. L. Alonso-Lebrero, et al. AM3 Modulates Dendritic Cell Pathogen Recognition Capabilities by Targeting DC-SIGN Antimicrob. Agents Chemother., July 1, 2007; 51(7): 2313 - 2323. [Abstract] [Full Text] [PDF]

				E. Falkowska, R. J. Durso, J. P. Gardner, E. G. Cormier, R. A. Arrigale, R. N. Ogawa, G. P. Donovan, P. J. Maddon, W. C. Olson, and T. Dragic L-SIGN (CD209L) isoforms differently mediate trans-infection of hepatoma cells by hepatitis C virus pseudoparticles J. Gen. Virol., September 1, 2006; 87(9): 2571 - 2576. [Abstract] [Full Text] [PDF]

				K. Nagaoka, K. Takahara, K. Tanaka, H. Yoshida, R. M. Steinman, S.-i. Saitoh, S. Akashi-Takamura, K. Miyake, Y. S. Kang, C. G. Park, et al. Association of SIGNR1 with TLR4-MD-2 enhances signal transduction by recognition of LPS in gram-negative bacteria Int. Immunol., July 1, 2005; 17(7): 827 - 836. [Abstract] [Full Text] [PDF]

				A. Lanoue, M. R. Clatworthy, P. Smith, S. Green, M. J. Townsend, H. E. Jolin, K. G.C. Smith, P. G. Fallon, and A. N.J. McKenzie SIGN-R1 Contributes to Protection against Lethal Pneumococcal Infection in Mice J. Exp. Med., December 6, 2004; 200(11): 1383 - 1393. [Abstract] [Full Text] [PDF]

				D. Serrano-Gomez, A. Dominguez-Soto, J. Ancochea, J. A. Jimenez-Heffernan, J. A. Leal, and A. L. Corbi Dendritic Cell-Specific Intercellular Adhesion Molecule 3-Grabbing Nonintegrin Mediates Binding and Internalization of Aspergillus fumigatus Conidia by Dendritic Cells and Macrophages J. Immunol., November 1, 2004; 173(9): 5635 - 5643. [Abstract] [Full Text] [PDF]

				J.-F. Arrighi, M. Pion, M. Wiznerowicz, T. B. Geijtenbeek, E. Garcia, S. Abraham, F. Leuba, V. Dutoit, O. Ducrey-Rundquist, Y. van Kooyk, et al. Lentivirus-Mediated RNA Interference of DC-SIGN Expression Inhibits Human Immunodeficiency Virus Transmission from Dendritic Cells to T Cells J. Virol., October 15, 2004; 78(20): 10848 - 10855. [Abstract] [Full Text] [PDF]

				H. Niiya, T. Azuma, L. Jin, N. Uchida, A. Inoue, H. Hasegawa, S. Fujita, M. Tohyama, K. Hashimoto, and M. Yasukawa Transcriptional downregulation of DC-SIGN in human herpesvirus 6-infected dendritic cells J. Gen. Virol., September 1, 2004; 85(9): 2639 - 2642. [Abstract] [Full Text] [PDF]

				E. Van Liempt, A. Imberty, C. M. C. Bank, S. J. Van Vliet, Y. Van Kooyk, T. B. H. Geijtenbeek, and I. Van Die Molecular Basis of the Differences in Binding Properties of the Highly Related C-type Lectins DC-SIGN and L-SIGN to Lewis X Trisaccharide and Schistosoma mansoni Egg Antigens J. Biol. Chem., August 6, 2004; 279(32): 33161 - 33167. [Abstract] [Full Text] [PDF]

				A. Puig-Kroger, D. Serrano-Gomez, E. Caparros, A. Dominguez-Soto, M. Relloso, M. Colmenares, L. Martinez-Munoz, N. Longo, N. Sanchez-Sanchez, M. Rincon, et al. Regulated Expression of the Pathogen Receptor Dendritic Cell-specific Intercellular Adhesion Molecule 3 (ICAM-3)-grabbing Nonintegrin in THP-1 Human Leukemic Cells, Monocytes, and Macrophages J. Biol. Chem., June 11, 2004; 279(24): 25680 - 25688. [Abstract] [Full Text] [PDF]

				K. Takahara, Y. Yashima, Y. Omatsu, H. Yoshida, Y. Kimura, Y.-S. Kang, R. M. Steinman, C. G. Park, and K. Inaba Functional comparison of the mouse DC-SIGN, SIGNR1, SIGNR3 and Langerin, C-type lectins Int. Immunol., June 1, 2004; 16(6): 819 - 829. [Abstract] [Full Text] [PDF]

				S. Ebner, Z. Ehammer, S. Holzmann, P. Schwingshackl, M. Forstner, P. Stoitzner, G. M. Huemer, P. Fritsch, and N. Romani Expression of C-type lectin receptors by subsets of dendritic cells in human skin Int. Immunol., June 1, 2004; 16(6): 877 - 887. [Abstract] [Full Text] [PDF]

				A. Engering, S. J. van Vliet, K. Hebeda, D. G. Jackson, R. Prevo, S. K. Singh, T. B. H. Geijtenbeek, H. van Krieken, and Y. van Kooyk Dynamic Populations of Dendritic Cell-Specific ICAM-3 Grabbing Nonintegrin-Positive Immature Dendritic Cells and Liver/Lymph Node-Specific ICAM-3 Grabbing Nonintegrin-Positive Endothelial Cells in the Outer Zones of the Paracortex of Human Lymph Nodes Am. J. Pathol., May 1, 2004; 164(5): 1587 - 1595. [Abstract] [Full Text] [PDF]

				S. V. Su, P. Hong, S. Baik, O. A. Negrete, K. B. Gurney, and B. Lee DC-SIGN Binds to HIV-1 Glycoprotein 120 in a Distinct but Overlapping Fashion Compared with ICAM-2 and ICAM-3 J. Biol. Chem., April 30, 2004; 279(18): 19122 - 19132. [Abstract] [Full Text] [PDF]

				E. Prina, S. Z. Abdi, M. Lebastard, E. Perret, N. Winter, and J.-C. Antoine Dendritic cells as host cells for the promastigote and amastigote stages of Leishmania amazonensis: the role of opsonins in parasite uptake and dendritic cell maturation J. Cell Sci., January 15, 2004; 117(2): 315 - 325. [Abstract] [Full Text] [PDF]

				M. Colmenares, A. L. Corbi, S. J. Turco, and L. Rivas The Dendritic Cell Receptor DC-SIGN Discriminates among Species and Life Cycle Forms of Leishmania J. Immunol., January 15, 2004; 172(2): 1186 - 1190. [Abstract] [Full Text] [PDF]

				A. Cambi, F. de Lange, N. M. van Maarseveen, M. Nijhuis, B. Joosten, E. M.H.P. van Dijk, B. I. de Bakker, J. A.M. Fransen, P. H.M. Bovee-Geurts, F. N. van Leeuwen, et al. Microdomains of the C-type lectin DC-SIGN are portals for virus entry into dendritic cells J. Cell Biol., January 5, 2004; 164(1): 145 - 155. [Abstract] [Full Text] [PDF]

				J. Chehimi, Q. Luo, L. Azzoni, L. Shawver, N. Ngoubilly, R. June, G. Jerandi, M. Farabaugh, and L. J. Montaner HIV-1 transmission and cytokine-induced expression of DC-SIGN in human monocyte-derived macrophages J. Leukoc. Biol., November 1, 2003; 74(5): 757 - 763. [Abstract] [Full Text] [PDF]

				R. Jotwani and C.W. Cutler Multiple Dendritic Cell (DC) Subpopulations in Human Gingiva and Association of Mature DCs with CD4+ T-cells in situ Journal of Dental Research, September 1, 2003; 82(9): 736 - 741. [Abstract] [Full Text] [PDF]

				D. McDonald, L. Wu, S. M. Bohks, V. N. KewalRamani, D. Unutmaz, and T. J. Hope Recruitment of HIV and Its Receptors to Dendritic Cell-T Cell Junctions Science, May 23, 2003; 300(5623): 1295 - 1297. [Abstract] [Full Text] [PDF]

				C. Nobile, A. Moris, F. Porrot, N. Sol-Foulon, and O. Schwartz Inhibition of Human Immunodeficiency Virus Type 1 Env-Mediated Fusion by DC-SIGN J. Virol., May 1, 2003; 77(9): 5313 - 5323. [Abstract] [Full Text] [PDF]

				J. P. Gardner, R. J. Durso, R. R. Arrigale, G. P. Donovan, P. J. Maddon, T. Dragic, and W. C. Olson L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus PNAS, April 15, 2003; 100(8): 4498 - 4503. [Abstract] [Full Text] [PDF]

				B. Tassaneetrithep, T. H. Burgess, A. Granelli-Piperno, C. Trumpfheller, J. Finke, W. Sun, M. A. Eller, K. Pattanapanyasat, S. Sarasombath, D. L. Birx, et al. DC-SIGN (CD209) Mediates Dengue Virus Infection of Human Dendritic Cells J. Exp. Med., April 7, 2003; 197(7): 823 - 829. [Abstract] [Full Text] [PDF]

				A. Puig-Kroger, O. Muniz-Pello, R. Selgas, G. Criado, M-A. Bajo, J. A. Sanchez-Tomero, V. Alvarez, G. del Peso, P. Sanchez-Mateos, C. Holmes, et al. Peritoneal dialysis solutions inhibit the differentiation and maturation of human monocyte-derived dendritic cells: effect of lactate and glucose-degradation products J. Leukoc. Biol., April 1, 2003; 73(4): 482 - 492. [Abstract] [Full Text] [PDF]

				N. Maeda, J. Nigou, J.-L. Herrmann, M. Jackson, A. Amara, P. H. Lagrange, G. Puzo, B. Gicquel, and O. Neyrolles The Cell Surface Receptor DC-SIGN Discriminates between Mycobacterium Species through Selective Recognition of the Mannose Caps on Lipoarabinomannan J. Biol. Chem., February 14, 2003; 278(8): 5513 - 5516. [Abstract] [Full Text] [PDF]

				L. Tailleux, O. Schwartz, J.-L. Herrmann, E. Pivert, M. Jackson, A. Amara, L. Legres, D. Dreher, L. P. Nicod, J. C. Gluckman, et al. DC-SIGN Is the Major Mycobacterium tuberculosis Receptor on Human Dendritic Cells J. Exp. Med., January 6, 2003; 197(1): 121 - 127. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) All Versions of this Article: 277/39/36766    most recent M205270200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Colmenares, M. Articles by Rivas, L. Search for Related Content PubMed PubMed Citation Articles by Colmenares, M. Articles by Rivas, L. Social Bookmarking                      What's this?